Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (200)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cruts, M.
Right arrow Articles by Van Broeckhoven, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cruts, M.
Right arrow Articles by Van Broeckhoven, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 7, 43-51, Copyright © 1998 by Oxford University Press


ARTICLES

Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease

M Cruts, CM van Duijn, H Backhovens, M Van den Broeck, A Wehnert, S Serneels, R Sherrington, M Hutton, J Hardy, PH St George-Hyslop, A Hofman and C Van Broeckhoven
Laboratory of Neurogenetics, Flanders Interuniversity Institute for Biotechnology (VIB), Born-Bunge Foundation (BBS), University of Antwerp (UIA), Department of Biochemistry, Antwerpen, Belgium.

Two closely related genes, the presenilins ( PS ), located at chromosomes 14q24.3 and 1q42.1, have been identified for autosomal dominant Alzheimer disease (AD) with onset age below 65 years (presenile AD). We performed a systematic mutation analysis of all coding and 5'-non-coding exons of PS -1 and PS -2 in a population-based epidemiological series of 101 unrelated familial and sporadic presenile AD cases. The familial cases included 10 patients of autosomal dominant AD families sampled for linkage analysis studies. In all patients mutations in the amyloid precursor protein gene ( APP ) had previously been excluded. Four different PS -1 missense mutations were identified in six familial cases, two of which where autosomal dominant cases. Three mutations resulted in onset ages above 55 years, with one segregating in an autosomal dominant family with mean onset age 64 years (range 50-78 years). One PS -2 mutation was identified in a sporadic case with onset age 62 years. Our mutation data provided estimates for PS -1 and PS -2 mutation frequencies in presenile AD of 6 and 1% respectively. When family history was accounted for mutation frequencies for PS -1 were 9% in familial cases and 18% in autosomal dominant cases. Further, polymorphisms were detected in the promoter and the 5'-non-coding region of PS -1 and in intronic and exonic sequences of PS -2 that will be useful in genetic association studies.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
L. Dintchov Traykov, S. Mehrabian, M. Van den Broeck, M. Radoslavova Raycheva, M. Cruts, A. Kirilova Jordanova, and C. Van Broeckhoven
Novel PSEN1 Mutation in a Bulgarian Patient With Very Early-Onset Alzheimer's Disease, Spastic Paraparesis, and Extrapyramidal Signs
American Journal of Alzheimer's Disease and Other Dementias, October 1, 2009; 24(5): 404 - 407.
[Abstract] [PDF]


Home page
Cereb CortexHome page
C. Cruchaga, M. A. Fernandez-Seara, M. Seijo-Martinez, L. Samaranch, E. Lorenzo, A. Hinrichs, J. Irigoyen, C. Maestro, E. Prieto, J. M. Marti-Climent, et al.
Cortical Atrophy and Language Network Reorganization Associated with a Novel Progranulin Mutation
Cereb Cortex, August 1, 2009; 19(8): 1751 - 1760.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Piscopo, G. Marcon, M. R. Piras, A. Crestini, L. M. Campeggi, E. Deiana, R. Cherchi, F. Tanda, A. Deplano, N. Vanacore, et al.
A novel PSEN2 mutation associated with a peculiar phenotype
Neurology, April 22, 2008; 70(17): 1549 - 1554.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K. L Brickell, J. B Leverenz, E. J Steinbart, M. Rumbaugh, G. D Schellenberg, D. Nochlin, T. H Lampe, I. E Holm, V. V. Deerlin, W. Yuan, et al.
Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1050 - 1055.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
C. K. Chai
The Genetics of Alzheimer's Disease
American Journal of Alzheimer's Disease and Other Dementias, February 1, 2007; 22(1): 37 - 41.
[Abstract] [PDF]


Home page
BrainHome page
K. Sleegers, N. Brouwers, I. Gijselinck, J. Theuns, D. Goossens, J. Wauters, J. Del-Favero, M. Cruts, C. M. v. Duijn, and C. V. Broeckhoven
APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy
Brain, November 1, 2006; 129(11): 2977 - 2983.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Preusser, T Strobel, E Gelpi, M Eiler, G Broessner, E Schmutzhard, and H Budka
Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting.
J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 413 - 416.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. G. Marrosu, G. Floris, G. Costa, L. Schirru, G. Spinicci, M. V. Cherchi, M. Mura, M. G. Mascia, and E. Cocco
Dementia, pyramidal system involvement, and leukoencephalopathy with a presenilin 1 mutation
Neurology, January 10, 2006; 66(1): 108 - 111.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
J. M. Ringman
What the Study of Persons At Risk for Familial Alzheimer's Disease Can Tell Us About the Earliest Stages of the Disorder: A Review
J Geriatr Psychiatry Neurol, December 1, 2005; 18(4): 228 - 233.
[Abstract] [PDF]


Home page
Arch NeurolHome page
B. J. Snider, J. Norton, M. A. Coats, S. Chakraverty, C. E. Hou, R. Jervis, C. L. Lendon, A. M. Goate, D. W. McKeel Jr, and J. C. Morris
Novel Presenilin 1 Mutation (S170F) Causing Alzheimer Disease With Lewy Bodies in the Third Decade of Life
Arch Neurol, December 1, 2005; 62(12): 1821 - 1830.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. S. Goldman, J. K. Johnson, K. McElligott, O. Suchowersky, B. L. Miller, and V. M. Van Deerlin
Presenilin 1 Glu318Gly Polymorphism: Interpret With Caution
Arch Neurol, October 1, 2005; 62(10): 1624 - 1627.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
P. H. Wen, R. De Gasperi, M. A. G. Sosa, A. B. Rocher, V. L. Friedrich Jr, P. R. Hof, and G. A. Elder
Selective expression of presenilin 1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin 1-null mutant mice
Development, September 1, 2005; 132(17): 3873 - 3883.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. K. Godbolt, K. A. Josephs, T. Revesz, E. K. Warrington, P. Lantos, A. King, N. C. Fox, S. Al Sarraj, J. Holton, L. Cipolotti, et al.
Sporadic and Familial Dementia With Ubiquitin-Positive Tau-Negative Inclusions: Clinical Features of One Histopathological Abnormality Underlying Frontotemporal Lobar Degeneration
Arch Neurol, July 1, 2005; 62(7): 1097 - 1101.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E A Croes, J Theuns, J J Houwing-Duistermaat, B Dermaut, K Sleegers, G Roks, M Van den Broeck, B van Harten, J C van Swieten, M Cruts, et al.
Octapeptide repeat insertions in the prion protein gene and early onset dementia
J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1166 - 1170.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Tedde, B. Nacmias, M. Ciantelli, P. Forleo, E. Cellini, S. Bagnoli, C. Piccini, P. Caffarra, E. Ghidoni, M. Paganini, et al.
Identification of New Presenilin Gene Mutations in Early-Onset Familial Alzheimer Disease
Arch Neurol, November 1, 2003; 60(11): 1541 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Ezquerra, A. Lleo, M. Castellvi, R. Queralt, P. Santacruz, P. Pastor, J. L. Molinuevo, R. Blesa, and R. Oliva
A Novel Mutation in the PSEN2 Gene (T430M) Associated With Variable Expression in a Family With Early-Onset Alzheimer Disease
Arch Neurol, August 1, 2003; 60(8): 1149 - 1151.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J-C Lambert, E Luedecking-Zimmer, S Merrot, A Hayes, U Thaker, P Desai, A Houzet, X Hermant, D Cottel, A Pritchard, et al.
Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease
J. Med. Genet., June 1, 2003; 40(6): 424 - 430.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Theuns, J. Remacle, R. Killick, E. Corsmit, K.'l Vennekens, D. Huylebroeck, M. Cruts, and C. V. Broeckhoven
Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression
Hum. Mol. Genet., April 15, 2003; 12(8): 869 - 877.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J.C. Janssen, J.A. Beck, T.A. Campbell, A. Dickinson, N.C. Fox, R.J. Harvey, H. Houlden, M.N. Rossor, and J. Collinge
Early onset familial Alzheimer's disease: Mutation frequency in 31 families
Neurology, January 28, 2003; 60(2): 235 - 239.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Lleo, R. Blesa, R. Queralt, M. Ezquerra, J. L. Molinuevo, J. Pena-Casanova, A. Rojo, and R. Oliva
Frequency of Mutations in the Presenilin and Amyloid Precursor Protein Genes in Early-Onset Alzheimer Disease in Spain
Arch Neurol, November 1, 2002; 59(11): 1759 - 1763.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
N. R. Graff-Radford, R. C. Green, R. C. P. Go, M. L. Hutton, T. Edeki, D. Bachman, J. L. Adamson, P. Griffith, F. B. Willis, M. Williams, et al.
Association Between Apolipoprotein E Genotype and Alzheimer Disease in African American Subjects
Arch Neurol, April 1, 2002; 59(4): 594 - 600.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R Queralt, M Ezquerra, A Lleo, M Castellvi, J Gelpi, I Ferrer, N Acarin, L Pasarin, R Blesa, and R Oliva
A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances
J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 266 - 269.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
C. HOLMES
Genotype and phenotype in Alzheimer's disease
The British Journal of Psychiatry, February 1, 2002; 180(2): 131 - 134.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
B. Dermaut, S. Kumar-Singh, C. De Jonghe, M. Cruts, A. Lofgren, U. Lubke, P. Cras, R. Dom, P. P. De Deyn, J. J. Martin, et al.
Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation
Brain, December 1, 2001; 124(12): 2383 - 2392.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Lleo, R. Blesa, J. Gendre, M. Castellvi, P. Pastor, R. Queralt, and R. Oliva
A novel presenilin 2 gene mutation (D439A) in a patient with early-onset Alzheimer's disease
Neurology, November 27, 2001; 57(10): 1926 - 1928.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. S. Athan, J. Williamson, A. Ciappa, V. Santana, S. N. Romas, J. H. Lee, H. Rondon, R. A. Lantigua, M. Medrano, M. Torres, et al.
A Founder Mutation in Presenilin 1 Causing Early-Onset Alzheimer Disease in Unrelated Caribbean Hispanic Families
JAMA, November 14, 2001; 286(18): 2257 - 2263.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K.A. Johnson, F. Lopera, K. Jones, A. Becker, R. Sperling, J. Hilson, J. Londono, I. Siegert, M. Arcos, S. Moreno, et al.
Presenilin-1-associated abnormalities in regional cerebral perfusion
Neurology, June 12, 2001; 56(11): 1545 - 1551.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J.-C. Lambert, D. M A Mann, J. M Harris, M.-C. Chartier-Harlin, A. Cumming, J. Coates, H. Lemmon, D. StClair, T. Iwatsubo, and C. Lendon
The {-}48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A{beta} load in brain
J. Med. Genet., June 1, 2001; 38(6): 353 - 355.
[Abstract] [Full Text]


Home page
BrainHome page
A. B. Singleton, R. Hall, C. G. Ballard, R. H. Perry, J. H. Xuereb, D. C. Rubinsztein, C. Tysoe, P. Matthews, B. Cordell, S. Kumar-Singh, et al.
Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation
Brain, December 1, 2000; 123(12): 2467 - 2474.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. J. Whalley, J. M. Starr, R. Athawes, D. Hunter, A. Pattie, and I. J. Deary
Childhood mental ability and dementia
Neurology, November 28, 2000; 55(10): 1455 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Kumar-Singh, C. De Jonghe, M. Cruts, R. Kleinert, R. Wang, M. Mercken, B. De Strooper, H. Vanderstichele, A. Lofgren, I. Vanderhoeven, et al.
Nonfibrillar diffuse amyloid deposition due to a {gamma}42-secretase site mutation points to an essential role for N-truncated A{beta}42 in Alzheimer's disease
Hum. Mol. Genet., November 1, 2000; 9(18): 2589 - 2598.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Theuns and C. Van Broeckhoven
Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility
Hum. Mol. Genet., October 1, 2000; 9(16): 2383 - 2394.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Tanahashi and T. Tabira
Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein
Hum. Mol. Genet., September 1, 2000; 9(15): 2281 - 2289.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Ezquerra, C. Carnero, R. Blesa, and R. Oliva
A Novel Presenilin 1 Mutation (Leu166Arg) Associated With Early-Onset Alzheimer Disease
Arch Neurol, April 1, 2000; 57(4): 485 - 488.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Verkkoniemi, M. Somer, J. O. Rinne, L. Myllykangas, R. Crook, J. Hardy, M. Viitanen, H. Kalimo, and M. Haltia
Variant Alzheimer's disease with spastic paraparesis: Clinical characterization
Neurology, March 14, 2000; 54(5): 1103 - 1109.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
T. D. Bird
Sporadic Cases of Possible Genetic Diseases: To Test or Not to Test?
Arch Neurol, March 1, 2000; 57(3): 309 - 310.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Theuns, J. Del-Favero, B. Dermaut, C. M. v. Duijn, H. Backhovens, M. V. d. Broeck, S. Serneels, E. Corsmit, C. V. Broeckhoven, and M. Cruts
Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression
Hum. Mol. Genet., February 12, 2000; 9(3): 325 - 331.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Leissring, I. Parker, and F. M. LaFerla
Presenilin-2 Mutations Modulate Amplitude and Kinetics of Inositol 1,4,5-Trisphosphate-mediated Calcium Signals
J. Biol. Chem., November 12, 1999; 274(46): 32535 - 32538.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. A. Johnston, C. L. Ward, and R. R. Kopito
Aggresomes: A Cellular Response to Misfolded Proteins
J. Cell Biol., December 28, 1998; 143(7): 1883 - 1898.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. G. Marrosu, G. Floris, G. Costa, L. Schirru, G. Spinicci, M. V. Cherchi, M. Mura, M. G. Mascia, and E. Cocco
Dementia, pyramidal system involvement, and leukoencephalopathy with a presenilin 1 mutation
Neurology, January 10, 2006; 66(1): 108 - 111.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.